SMTL ID : 9mqi.1

Inactive Mu-Opioid Receptor with Nb6M, NabFab, and isoquinuclidine compound #020_E1

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-1-mer

Ligands

1 x 01: methyl (1S,3R,4S,6S,8M)-2-[(1-ethyl-1H-pyrazol-4-yl)methyl]-8-(3-hydroxyphenyl)-3,4-dimethyl-2-azabicyclo[2.2.2]oct-7-ene-6-carboxylate

01.1: 11 residues within 4Å: Chain A: Y.141, D.160, Y.161, M.164, K.246, W.306, I.309, H.310, V.313, I.335, Y.339 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:D.160, A:I.309, A:V.313, A:V.313, A:I.335 Salt bridges: A:D.160 pi-Stacking: A:H.310

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Vigneron, S.F. et al., Docking 14 million virtual isoquinuclidines against the mu and kappa opioid receptors reveals dual antagonists-inverse agonists with reduced withdrawal effects. Biorxiv (2025)

Release Date

2025-02-12

Peptides

Mu-type opioid receptor: A
Nanobody 6M: B
NabFab Heavy Chain: C
NabFab Light Chain: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

C
H

D
L

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Mu-type opioid receptor

Nanobody 6M

NabFab Heavy Chain

NabFab Light Chain

Related Entries With Identical Sequence